Shilpa Naik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shilpa Naik has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Jyoti S. Mathad
Department of Medicine and Obstetrics and Gynecology, Center for Global Health, Weill Cornell Medicine, New York, New York, USA
5 shared publications - Mallika Alexander
Center for Global Health Weill Cornell Medicine New York City New York USA
5 shared publications - Amita Gupta
Division of Infectious Diseases, School of Medicine, Johns Hopkins University , Baltimore, Maryland
4 shared publications Aditi Kole
Byramjee Jeejeebhoy Government Medical College–Johns Hopkins University Clinical Research Site Pune India
2 shared publicationsAjay Chandanwale
Byramjee Jeejeebhoy Government Medical College/Sassoon General Hospitals, Jay Prakash Narayan Road, Pune, 411001, Maharashtra, India
2 shared publicationsAmita Gupta
Division of Infectious Diseases, Johns Hopkins University School of Medicine, MD, USA
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Wiley in Reproductive, Female and Child Health
- Vol. 5 (4)
Gestational Diabetes Awareness Is Low Among Low‐Income Pregnant Women Attending a Public Antenatal Clinic in Pune, India
Objective: Gestational Diabetes (GDM) is increasingly common and associated with adverse outcomes, yet awareness remains low in many settings. We examined factors associated with GDM awareness among low and middle‐income pregnant women in India. Methods: Pregnant women were enrolled at a government hospital in Pune, India. Participants were asked if they had heard of diabetes and, if so, completed a 12‐item questionnaire assessing knowledge of GDM risk factors, testing and treatment, and consequences. Each correct response scored 1 point; scores of 0–4 were classified as poor awareness, 5–8 as fair, and 9–12 as good. Suboptimal awareness was defined as poor, fair, or no awareness. A multivariable logistic regression was used to assess risk factors for suboptimal awareness. Results: Among 368 women, median age was 25 years (IQR 22–29), gestational age 20.4 weeks (IQR 16.5–24.0), BMI 22.8 kg/m 2 (IQR 20–26.9); 33% ( n = 122) were primigravid, 31% ( n = 114) living with HIV, and 11% ( n = 41) had GDM. Among 326 (89%) of women who were aware of diabetes, median GDM awareness score was 9 (IQR 7–10). Overall, 197/368 (54%) women had suboptimal awareness. On multivariable analysis adjusting for residence, gravidity, and BMI, living with HIV (aOR 1.7, 95% CI 1.0–2.8, p = 0.04) and lower socioeconomic status (aOR 1.9, 95% CI 1.1, 3.2) were independently associated with odds of suboptimal GDM awareness. Conclusions: GDM awareness remains suboptimal among low‐income pregnant women in India, particularly among women with HIV. Targeted educational health interventions may improve awareness and reduce long‐term complications.
- 27 October 2026
- Published by Wiley in Reproductive, Female and Child Health
- Vol. 5 (4)
Open AccessGestational Diabetes Awareness Is Low Among Low‐Income Pregnant Women Attending a Public Antenatal Clinic in Pune, India
Objective: Gestational Diabetes (GDM) is increasingly common and associated with adverse outcomes, yet awareness remains low in many settings. We examined factors associated with GDM awareness among low and middle‐income pregnant women in India. Methods: Pregnant women were enrolled at a government hospital in Pune, India. Participants were asked if they had heard of diabetes and, if so, completed a 12‐item questionnaire assessing knowledge of GDM risk factors, testing and treatment, and consequences. Each correct response scored 1 point; scores of 0–4 were classified as poor awareness, 5–8 as fair, and 9–12 as good. Suboptimal awareness was defined as poor, fair, or no awareness. A multivariable logistic regression was used to assess risk factors for suboptimal awareness. Results: Among 368 women, median age was 25 years (IQR 22–29), gestational age 20.4 weeks (IQR 16.5–24.0), BMI 22.8 kg/m 2 (IQR 20–26.9); 33% ( n = 122) were primigravid, 31% ( n = 114) living with HIV, and 11% ( n = 41) had GDM. Among 326 (89%) of women who were aware of diabetes, median GDM awareness score was 9 (IQR 7–10). Overall, 197/368 (54%) women had suboptimal awareness. On multivariable analysis adjusting for residence, gravidity, and BMI, living with HIV (aOR 1.7, 95% CI 1.0–2.8, p = 0.04) and lower socioeconomic status (aOR 1.9, 95% CI 1.1, 3.2) were independently associated with odds of suboptimal GDM awareness. Conclusions: GDM awareness remains suboptimal among low‐income pregnant women in India, particularly among women with HIV. Targeted educational health interventions may improve awareness and reduce long‐term complications.
- Open Access
- 20 September 2026
- Published by Wiley in Journal of the International AIDS Society
- Vol. 29 (9) , e70200
Dolutegravir Is Associated With Lower Odds of Gestational Diabetes Compared to Other Antiretroviral Therapy Regimens Among Pregnant Women in India: A Cross‐Sectional Analysis
Introduction: In non‐pregnant adults living with HIV, dolutegravir is associated with weight gain and increased type 2 diabetes risk. In pregnancy, data on the effect of dolutegravir on gestational diabetes (GDM) risk is inconclusive. Data are particularly limited in Asian populations, where diabetes risk is especially high and not always associated with weight gain. We examined the association of dolutegravir with GDM among women living with HIV in India. Methods: We combined data from two cohorts of pregnant women living with HIV conducted at BJ Government Medical College in Pune, India—the PRACHITi study (2016−2019) and the PRAGATHi study (2023−present). Women were screened for GDM with the fasting 2‐h 75 g oral glucose tolerance test and diagnosed by World Health Organization criteria. Demographics, anthropometrics, antiretroviral therapy (ART), CD4 count and HIV viral load were collected at screening. Multivariate logistic regression was used to determine the association between current dolutegravir use and GDM. Results: Of 254 women living with HIV, 99.2% ( n = 252) were on ART, of whom 66.3% ( n = 167) were on dolutegravir‐, 22.6% ( n = 57) were on efavirenz‐ and 6.3% ( n = 16) were on protease inhibitor (PI)‐based ART. Overall, median CD4 count was 549.5 cells/mm 3 (IQR 401−753), and 82.2% ( n = 198) had undetectable viral load. Median body‐mass index (BMI) was 21.3 kg/m 2 (IQR 19.4−23.8). The prevalence of GDM was 11.8% ( N = 30). Among women on dolutegravir‐based ART, the prevalence was 10.8% ( N = 18); among women on efavirenz‐based ART, the prevalence was 12.3% ( N = 7), and the prevalence was 25% ( N = 4) among women on PI‐based ART. Compared to women not taking dolutegravir, women taking dolutegravir had similar age and BMI but greater weight gain from the second to the third trimester (3.7 vs. 2.9 kg, p p 2 , 95% CI 1.1−1.3) were also associated with GDM. Conclusions: Women on dolutegravir had lower odds of GDM compared to women taking other ART, despite greater weight gain. Ongoing studies are investigating the possible anti‐inflammatory mechanisms.
- 20 September 2026
- Published by Wiley in Journal of the International AIDS Society
- Vol. 29 (9) , e70200
Open AccessDolutegravir Is Associated With Lower Odds of Gestational Diabetes Compared to Other Antiretroviral Therapy Regimens Among Pregnant Women in India: A Cross‐Sectional Analysis
Introduction: In non‐pregnant adults living with HIV, dolutegravir is associated with weight gain and increased type 2 diabetes risk. In pregnancy, data on the effect of dolutegravir on gestational diabetes (GDM) risk is inconclusive. Data are particularly limited in Asian populations, where diabetes risk is especially high and not always associated with weight gain. We examined the association of dolutegravir with GDM among women living with HIV in India. Methods: We combined data from two cohorts of pregnant women living with HIV conducted at BJ Government Medical College in Pune, India—the PRACHITi study (2016−2019) and the PRAGATHi study (2023−present). Women were screened for GDM with the fasting 2‐h 75 g oral glucose tolerance test and diagnosed by World Health Organization criteria. Demographics, anthropometrics, antiretroviral therapy (ART), CD4 count and HIV viral load were collected at screening. Multivariate logistic regression was used to determine the association between current dolutegravir use and GDM. Results: Of 254 women living with HIV, 99.2% ( n = 252) were on ART, of whom 66.3% ( n = 167) were on dolutegravir‐, 22.6% ( n = 57) were on efavirenz‐ and 6.3% ( n = 16) were on protease inhibitor (PI)‐based ART. Overall, median CD4 count was 549.5 cells/mm 3 (IQR 401−753), and 82.2% ( n = 198) had undetectable viral load. Median body‐mass index (BMI) was 21.3 kg/m 2 (IQR 19.4−23.8). The prevalence of GDM was 11.8% ( N = 30). Among women on dolutegravir‐based ART, the prevalence was 10.8% ( N = 18); among women on efavirenz‐based ART, the prevalence was 12.3% ( N = 7), and the prevalence was 25% ( N = 4) among women on PI‐based ART. Compared to women not taking dolutegravir, women taking dolutegravir had similar age and BMI but greater weight gain from the second to the third trimester (3.7 vs. 2.9 kg, p p 2 , 95% CI 1.1−1.3) were also associated with GDM. Conclusions: Women on dolutegravir had lower odds of GDM compared to women taking other ART, despite greater weight gain. Ongoing studies are investigating the possible anti‐inflammatory mechanisms.
- 14 September 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (3) , 569-572
The Association of Gestational Diabetes with HIV Infection and Tuberculosis in Indian Women
: Infection of HIV is associated with an increased diabetes risk, which also increases tuberculosis risk. It is unknown if similar associations exist with gestational diabetes (GDM). We screened pregnant women living with and without HIV for GDM using oral glucose tolerance testing. In a subgroup of women with latent tuberculosis (positive interferon-gamma [IFN-γ] release assay), we used supernatants from tuberculosis antigen tubes to compare cytokine levels from women with and without GDM, matched by age and HIV status. Of 234 women, 21 (9%) had GDM, 13.9% living with HIV, and 6.5% without HIV (P = 0.06). Compared with women without GDM, women with GDM had lower median IFN-γ (19.1 versus 141.9 pg/mL, P = 0.03) and interleukin-2 (18.7 versus 249 pg/mL, P < 0.01). Our study suggests that HIV infection is associated with an increased risk of GDM, which is associated with decreased Mycobacterium tuberculosis immune responses. Gestational diabetes screening should be prioritized in tuberculosis-endemic countries, especially in women living with HIV.
- 14 September 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (3) , 569-572
The Association of Gestational Diabetes with HIV Infection and Tuberculosis in Indian Women
: Infection of HIV is associated with an increased diabetes risk, which also increases tuberculosis risk. It is unknown if similar associations exist with gestational diabetes (GDM). We screened pregnant women living with and without HIV for GDM using oral glucose tolerance testing. In a subgroup of women with latent tuberculosis (positive interferon-gamma [IFN-γ] release assay), we used supernatants from tuberculosis antigen tubes to compare cytokine levels from women with and without GDM, matched by age and HIV status. Of 234 women, 21 (9%) had GDM, 13.9% living with HIV, and 6.5% without HIV (P = 0.06). Compared with women without GDM, women with GDM had lower median IFN-γ (19.1 versus 141.9 pg/mL, P = 0.03) and interleukin-2 (18.7 versus 249 pg/mL, P < 0.01). Our study suggests that HIV infection is associated with an increased risk of GDM, which is associated with decreased Mycobacterium tuberculosis immune responses. Gestational diabetes screening should be prioritized in tuberculosis-endemic countries, especially in women living with HIV.
- 16 July 2022
- Published by Springer Nature in Archives of Microbiology
- Vol. 204 (8) , 1-16
Cervicovaginal microbiota isolated from healthy women exhibit probiotic properties and antimicrobial activity against pathogens isolated from cervical cancer patients
Abnormal cervicovaginal microbiota play an important role in HPV persistence and progression to cervical cancer. The present study aimed at isolating and identifying potential probiotics from vaginal swabs of healthy women and evaluating their activity against vaginal pathogens isolated from cervical cancer patients. Based on probiotic, acid-bile tolerance and antimicrobial properties, 13 lactic acid bacteria (LAB) from the healthy group were identified by MALDI TOF MS (Matrix Assisted Laser Desorption and Ionisation, Time Of Flight Mass Spectrometry). Among these, four strains, Lactobacillus gasseri P36Mops, Limosilactobacillus fermentum P37Mws, Lactobacillus delbrueckii P31Mcs and Enterococcus faecium P26Mcm, exhibited significant antimicrobial activity against 8 vaginal pathogens (Staphylococcus haemolyticus P41Tcs, Escherichia coli P30Tcs, E. coli P79Bcm, Enterococus faecalis P29Mops, E. faecalis P50Tws, E. faecalis P68Tcb, S. haemolyticus P48Bcb and S. haemolyticus P58Bcb) isolated from precancerous and cervical cancer patients. 16S rRNA sequencing of four potential probiotics revealed congruency with the MALDI-TOF MS identification and phylogenetic analysis showed genetic relationship with previously reported LAB strains. The selected LAB showed strain specific hydrophobicity (35.88–56.70%), auto-aggregation (35.26–61.39%) and antibiotic susceptibility. Interestingly, L. gasseri P36Mops was resistant to five standard antibiotics routinely used against urogenital or vaginal infections. LCMS (Liquid Chromatography Mass Spectrometry) analyses of the CFS (cell-free supernatant) of the four potential probiotics revealed the presence of metabolites such as N-(1-deoxy-1-fructosyl)valine, hygroline, acetoxy-2-hydroxy-16-heptadecen-4-one, avocadyne 4-acetate, avocadyne 2-acetate, taraxinic acid glucosyl ester, 6-hydroxypentadecanedioic acid, with reported antimicrobial activity. The overall data suggest the bio-therapeutic potential of the identified vaginal probiotics against cervical cancer-associated pathogens.
- 16 July 2022
- Published by Springer Nature in Archives of Microbiology
- Vol. 204 (8) , 1-16
Cervicovaginal microbiota isolated from healthy women exhibit probiotic properties and antimicrobial activity against pathogens isolated from cervical cancer patients
Abnormal cervicovaginal microbiota play an important role in HPV persistence and progression to cervical cancer. The present study aimed at isolating and identifying potential probiotics from vaginal swabs of healthy women and evaluating their activity against vaginal pathogens isolated from cervical cancer patients. Based on probiotic, acid-bile tolerance and antimicrobial properties, 13 lactic acid bacteria (LAB) from the healthy group were identified by MALDI TOF MS (Matrix Assisted Laser Desorption and Ionisation, Time Of Flight Mass Spectrometry). Among these, four strains, Lactobacillus gasseri P36Mops, Limosilactobacillus fermentum P37Mws, Lactobacillus delbrueckii P31Mcs and Enterococcus faecium P26Mcm, exhibited significant antimicrobial activity against 8 vaginal pathogens (Staphylococcus haemolyticus P41Tcs, Escherichia coli P30Tcs, E. coli P79Bcm, Enterococus faecalis P29Mops, E. faecalis P50Tws, E. faecalis P68Tcb, S. haemolyticus P48Bcb and S. haemolyticus P58Bcb) isolated from precancerous and cervical cancer patients. 16S rRNA sequencing of four potential probiotics revealed congruency with the MALDI-TOF MS identification and phylogenetic analysis showed genetic relationship with previously reported LAB strains. The selected LAB showed strain specific hydrophobicity (35.88–56.70%), auto-aggregation (35.26–61.39%) and antibiotic susceptibility. Interestingly, L. gasseri P36Mops was resistant to five standard antibiotics routinely used against urogenital or vaginal infections. LCMS (Liquid Chromatography Mass Spectrometry) analyses of the CFS (cell-free supernatant) of the four potential probiotics revealed the presence of metabolites such as N-(1-deoxy-1-fructosyl)valine, hygroline, acetoxy-2-hydroxy-16-heptadecen-4-one, avocadyne 4-acetate, avocadyne 2-acetate, taraxinic acid glucosyl ester, 6-hydroxypentadecanedioic acid, with reported antimicrobial activity. The overall data suggest the bio-therapeutic potential of the identified vaginal probiotics against cervical cancer-associated pathogens.
- Open Access
- 24 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26298
Clinical Profile of SARS-CoV-2-Infected Neonates
There are conflicting data on the mother-to-child transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and few studies have described the clinical course of neonates infected with SARS-CoV-2. This study investigates the mother-to-child transmission rate and clinical profile of SARS-CoV-2-infected newborns. Data on 304 newborns of 301 mothers with coronavirus disease 2019 (COVID-19) were prospectively collected and analyzed. Reverse transcription-polymerase chain reaction (RT-PCR) determined the presence of SARS-CoV-2 in the placenta, umbilical cord stump, and nasopharyngeal swabs collected within 24h of birth. Clinical and laboratory data of SARS-CoV-2-infected newborns was entered in a structured proforma. A total of 20 neonates (6.5%) were positive for SARS-CoV-2, of which 12 were positive only in the nasopharyngeal swab, four cases had the umbilical stump positive, three were positive in the placenta, and one case was positive in all the three specimens collected. Six of the 20 SARS-CoV-2-positive neonates developed severe symptoms. The SARS-CoV-2-positive symptomatic neonates required a more extended stay in hospital compared to their non-symptomatic infected counterparts. A proportion of the babies born to SARS-CoV2-infected mothers tested positive and some of these newborns had severe symptoms.
- 24 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26298
Open AccessClinical Profile of SARS-CoV-2-Infected Neonates
There are conflicting data on the mother-to-child transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and few studies have described the clinical course of neonates infected with SARS-CoV-2. This study investigates the mother-to-child transmission rate and clinical profile of SARS-CoV-2-infected newborns. Data on 304 newborns of 301 mothers with coronavirus disease 2019 (COVID-19) were prospectively collected and analyzed. Reverse transcription-polymerase chain reaction (RT-PCR) determined the presence of SARS-CoV-2 in the placenta, umbilical cord stump, and nasopharyngeal swabs collected within 24h of birth. Clinical and laboratory data of SARS-CoV-2-infected newborns was entered in a structured proforma. A total of 20 neonates (6.5%) were positive for SARS-CoV-2, of which 12 were positive only in the nasopharyngeal swab, four cases had the umbilical stump positive, three were positive in the placenta, and one case was positive in all the three specimens collected. Six of the 20 SARS-CoV-2-positive neonates developed severe symptoms. The SARS-CoV-2-positive symptomatic neonates required a more extended stay in hospital compared to their non-symptomatic infected counterparts. A proportion of the babies born to SARS-CoV2-infected mothers tested positive and some of these newborns had severe symptoms.
- 1 January 2021
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 68 (1) , 85-91
Detection of genital tuberculosis among women with infertility using best clinical practices in India: An implementation study
- 1 January 2021
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 68 (1) , 85-91
Detection of genital tuberculosis among women with infertility using best clinical practices in India: An implementation study
- Open Access
- 28 December 2020
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 126 (8) , 1247-1256
Validation of New Interactive Nutrition Assistant - Diet in India Study of Health (NINA-DISH) FFQ with multiple 24-h dietary recalls among pregnant women in Pune, India
Adequate dietary intake is critical to prevent adverse pregnancy outcomes. India has a high burden of maternal and child morbidity and mortality, but there is a lack of adequate tools to assess dietary intake. We validate an FFQ, New Interactive Nutrition Assistant - Diet in India Study of Health (NINA-DISH), among pregnant women living with and without HIV in Pune, India. Women were selected from a cohort study investigating immune responses to HIV and latent tuberculosis during pregnancy. The FFQ was administered during the third trimester and validated against multiple 24-h dietary recalls (24-HDR) collected in second and third trimesters. Data for analysis were available from fifty-eight women out of seventy enrolled into this sub-study, after excluding those with incomplete data or implausible energy intake. The median (Q1, Q3) age of study participants was 23 (20, 25) years. Median (Q1, Q3) daily energy intakes were 10 552 (8000, 11 958) and 10 673 (8510, 13 962) kJ by 24-HDR and FFQ, respectively, with FFQ overestimating nutrient intake. Pearson correlations between log-transformed estimates from FFQ and 24-HDR for energy, protein, carbohydrate, fat, Fe and Zn were 0·47, 0·48, 0·45, 0·33, 0·4 and 0·54, respectively. Energy-adjusted and de-attenuated correlations ranged from 0·41 (saturated fat) to 0·73 (Na). The highest misclassification into extreme tertiles was observed for fat (22 %), saturated fat (21 %) and Na (21 %). Bias existed at higher intake levels as observed by Bland–Altman plots. In conclusion, NINA-DISH is a valid and feasible tool for estimating dietary intakes among urban pregnant women in Western India.
- 28 December 2020
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 126 (8) , 1247-1256
Open AccessValidation of New Interactive Nutrition Assistant - Diet in India Study of Health (NINA-DISH) FFQ with multiple 24-h dietary recalls among pregnant women in Pune, India
Adequate dietary intake is critical to prevent adverse pregnancy outcomes. India has a high burden of maternal and child morbidity and mortality, but there is a lack of adequate tools to assess dietary intake. We validate an FFQ, New Interactive Nutrition Assistant - Diet in India Study of Health (NINA-DISH), among pregnant women living with and without HIV in Pune, India. Women were selected from a cohort study investigating immune responses to HIV and latent tuberculosis during pregnancy. The FFQ was administered during the third trimester and validated against multiple 24-h dietary recalls (24-HDR) collected in second and third trimesters. Data for analysis were available from fifty-eight women out of seventy enrolled into this sub-study, after excluding those with incomplete data or implausible energy intake. The median (Q1, Q3) age of study participants was 23 (20, 25) years. Median (Q1, Q3) daily energy intakes were 10 552 (8000, 11 958) and 10 673 (8510, 13 962) kJ by 24-HDR and FFQ, respectively, with FFQ overestimating nutrient intake. Pearson correlations between log-transformed estimates from FFQ and 24-HDR for energy, protein, carbohydrate, fat, Fe and Zn were 0·47, 0·48, 0·45, 0·33, 0·4 and 0·54, respectively. Energy-adjusted and de-attenuated correlations ranged from 0·41 (saturated fat) to 0·73 (Na). The highest misclassification into extreme tertiles was observed for fat (22 %), saturated fat (21 %) and Na (21 %). Bias existed at higher intake levels as observed by Bland–Altman plots. In conclusion, NINA-DISH is a valid and feasible tool for estimating dietary intakes among urban pregnant women in Western India.
- Open Access
Association of Vegetable and Animal Flesh Intake with Inflammation in Pregnant Women from India
In pregnant women, studies are lacking on the relationship of vegetable and animal flesh (poultry, red meat and seafood) intake with inflammation, especially in low- and middle-income countries. We conducted a cohort study of pregnant women receiving antenatal care at BJ Medical College in Pune, India. The dietary intake of pregnant women was queried in the third trimester using a validated food frequency questionnaire. Twelve inflammatory markers were measured in plasma samples using immunoassays. Only 12% of the study population were vegetarians, although animal flesh intake levels were lower compared to Western populations. In multivariable models, higher intakes of total vegetables were associated with lower levels of the T-helper (Th) 17 cytokine interleukin (IL)-17a (p = 0.03) and the monocyte/macrophage activation marker soluble CD163 (sCD163) (p = 0.02). Additionally, higher intakes of poultry were negatively associated with intestinal fatty-acid binding protein (I-FABP) levels (p = 0.01), a marker of intestinal barrier dysfunction and Th2 cytokine IL-13 (p = 0.03), and higher seafood was associated with lower IL-13 (p = 0.005). Our data from pregnant women in India suggest that a higher quality diet emphasizing vegetables and with some animal flesh is associated with lower inflammation. Future studies should confirm these findings and test if modulating vegetables and animal flesh intake could impact specific aspects of immunity and perinatal health.
Open AccessAssociation of Vegetable and Animal Flesh Intake with Inflammation in Pregnant Women from India
In pregnant women, studies are lacking on the relationship of vegetable and animal flesh (poultry, red meat and seafood) intake with inflammation, especially in low- and middle-income countries. We conducted a cohort study of pregnant women receiving antenatal care at BJ Medical College in Pune, India. The dietary intake of pregnant women was queried in the third trimester using a validated food frequency questionnaire. Twelve inflammatory markers were measured in plasma samples using immunoassays. Only 12% of the study population were vegetarians, although animal flesh intake levels were lower compared to Western populations. In multivariable models, higher intakes of total vegetables were associated with lower levels of the T-helper (Th) 17 cytokine interleukin (IL)-17a (p = 0.03) and the monocyte/macrophage activation marker soluble CD163 (sCD163) (p = 0.02). Additionally, higher intakes of poultry were negatively associated with intestinal fatty-acid binding protein (I-FABP) levels (p = 0.01), a marker of intestinal barrier dysfunction and Th2 cytokine IL-13 (p = 0.03), and higher seafood was associated with lower IL-13 (p = 0.005). Our data from pregnant women in India suggest that a higher quality diet emphasizing vegetables and with some animal flesh is associated with lower inflammation. Future studies should confirm these findings and test if modulating vegetables and animal flesh intake could impact specific aspects of immunity and perinatal health.
- Open Access
- 1 April 2020
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 26 (4) , 738-743
Intensified Short Symptom Screening Program for Dengue Infection during Pregnancy, India
Mosquitoborne diseases (e.g., malaria, dengue, and chikungunya) are endemic to India and pose diagnostic challenges during pregnancy. We evaluated an intensified short symptom screening program in India to diagnose dengue during pregnancy. During October 2017–January 2018, we screened pregnant women during antenatal surveillance for symptoms of mosquitoborne diseases (fever only, fever with conjunctivitis, fever with rash, or all 3 symptoms) within the previous 15 days . Of 5,843 pregnant women screened, 52 were enrolled and tested for dengue, chikungunya, and Zika viruses by using a Trioplex real-time reverse transcription PCR. Of 49 who had complete results, 7 (14%) were dengue positive. Ocular pain was seen in 28 (57%) and conjunctivitis in 49 (100%) of the patients with complete results. Intensified symptom screening using conjunctivitis, in addition to rash, in pregnant women with fever might improve dengue case detection and can be included in routine symptom screening during pregnancy.
- 1 April 2020
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 26 (4) , 738-743
Open AccessIntensified Short Symptom Screening Program for Dengue Infection during Pregnancy, India
Mosquitoborne diseases (e.g., malaria, dengue, and chikungunya) are endemic to India and pose diagnostic challenges during pregnancy. We evaluated an intensified short symptom screening program in India to diagnose dengue during pregnancy. During October 2017–January 2018, we screened pregnant women during antenatal surveillance for symptoms of mosquitoborne diseases (fever only, fever with conjunctivitis, fever with rash, or all 3 symptoms) within the previous 15 days . Of 5,843 pregnant women screened, 52 were enrolled and tested for dengue, chikungunya, and Zika viruses by using a Trioplex real-time reverse transcription PCR. Of 49 who had complete results, 7 (14%) were dengue positive. Ocular pain was seen in 28 (57%) and conjunctivitis in 49 (100%) of the patients with complete results. Intensified symptom screening using conjunctivitis, in addition to rash, in pregnant women with fever might improve dengue case detection and can be included in routine symptom screening during pregnancy.
- Open Access
- 14 September 2018
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 17, 914-915
Ovarian mass - tuberculosis or malignancy? Need for early intensified evaluation
- 14 September 2018
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 17, 914-915
Open AccessOvarian mass - tuberculosis or malignancy? Need for early intensified evaluation